Sabra Healthcare earnings test: Can portfolio shift offset headwinds? By Investing.com

Sabra Healthcare REIT Inc. is set to report second-quarter earnings, with investors focused on whether its portfolio transformation can sustain momentum after shares reached a five-year high. Analysts anticipate modest sequential EPS growth but a year-over-year decline, with revenue expected to slip slightly. The company recently announced significant portfolio reshaping, including re-tenanting Avamere properties and exiting a $300 million mortgage, leading to raised full-year guidance and a 9% stock surge.